Foretelling Early Lung Disease Progression in Cystic Fibrosis: The Combined Benefits of Magnetic Resonance Imaging and Newborn Screening.
作者信息
Goralski Jennifer L
机构信息
Division of Pediatric Pulmonology The University of North Carolina at Chapel Hill Chapel Hill, North Carolina.
出版信息
Am J Respir Crit Care Med. 2021 Oct 15;204(8):880-881. doi: 10.1164/rccm.202107-1727ED.
Abstract
摘要
相似文献
1
Foretelling Early Lung Disease Progression in Cystic Fibrosis: The Combined Benefits of Magnetic Resonance Imaging and Newborn Screening.预测囊性纤维化早期肺部疾病进展：磁共振成像与新生儿筛查的联合益处
Am J Respir Crit Care Med. 2021 Oct 15;204(8):880-881. doi: 10.1164/rccm.202107-1727ED.
2
Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis.磁共振成像检测肺疾病进展和新生儿筛查对学龄前囊性纤维化儿童的影响。
Am J Respir Crit Care Med. 2021 Oct 15;204(8):943-953. doi: 10.1164/rccm.202102-0278OC.
3
The remaining barriers to normalcy in CF: Advances in assessment of CF lung disease.CF 患者恢复正常生活的剩余障碍：CF 肺部疾病评估的进展。
Pediatr Pulmonol. 2021 Feb;56 Suppl 1:S90-S96. doi: 10.1002/ppul.24929.
4
Progression of early structural lung disease in young children with cystic fibrosis assessed using CT.使用 CT 评估小儿囊性纤维化早期结构性肺疾病的进展。
Thorax. 2012 Jun;67(6):509-16. doi: 10.1136/thoraxjnl-2011-200912. Epub 2011 Dec 26.
5
Chest magnetic resonance imaging in cystic fibrosis: technique and clinical benefits.囊性纤维化的胸部磁共振成像：技术和临床获益。
Pediatr Radiol. 2023 Apr;53(4):640-648. doi: 10.1007/s00247-022-05539-9. Epub 2022 Nov 14.
6
Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis.肺清除指数与磁共振成像在儿童囊性纤维化肺部疾病评估中的比较。
Am J Respir Crit Care Med. 2017 Feb 1;195(3):349-359. doi: 10.1164/rccm.201604-0893OC.
7
The Swiss Cystic Fibrosis Infant Lung Development (SCILD) cohort.瑞士囊性纤维化婴儿肺部发育（SCILD）队列研究。
Swiss Med Wkly. 2018 Apr 26;148:w14618. doi: 10.4414/smw.2018.14618. eCollection 2018.
8
Structural and perfusion magnetic resonance imaging of the lung in cystic fibrosis.囊性纤维化患者肺部的结构与灌注磁共振成像
Pediatr Radiol. 2018 Feb;48(2):165-175. doi: 10.1007/s00247-017-4021-8. Epub 2017 Nov 15.
9
Cystic fibrosis infant care challenges in diagnosis and management in the era of newborn screening.新生儿筛查时代囊性纤维化婴儿护理在诊断和管理方面面临的挑战。
Del Med J. 2012 May;84(5):149-55.
10
Contrast-enhanced Magnetic Resonance Imaging Does Not Detect a Progression in Lung Morphological Score in Preschool Children with Cystic Fibrosis.对比增强磁共振成像未检测到囊性纤维化学龄前儿童肺部形态学评分的进展。
Am J Respir Crit Care Med. 2022 Jan 1;205(1):134. doi: 10.1164/rccm.202107-1747LE.
本文引用的文献
1
Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis.磁共振成像检测肺疾病进展和新生儿筛查对学龄前囊性纤维化儿童的影响。
Am J Respir Crit Care Med. 2021 Oct 15;204(8):943-953. doi: 10.1164/rccm.202102-0278OC.
2
Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial.依伐卡托特在 4 至<12 个月患有囊性纤维化且存在门控突变婴儿中的应用。两项 3 期临床试验的结果。
Am J Respir Crit Care Med. 2021 Mar 1;203(5):585-593. doi: 10.1164/rccm.202008-3177OC.
3
Novel imaging techniques for cystic fibrosis lung disease.囊性纤维化肺病的新型影像学技术。
Pediatr Pulmonol. 2021 Feb;56 Suppl 1(Suppl 1):S40-S54. doi: 10.1002/ppul.24931.
4
Structural determinants of long-term functional outcomes in young children with cystic fibrosis.囊性纤维化患儿长期功能结局的结构决定因素。
Eur Respir J. 2020 May 21;55(5). doi: 10.1183/13993003.00748-2019. Print 2020 May.
5
Minimal change in structural, functional and inflammatory markers of lung disease in newborn screened infants with cystic fibrosis at one year.患有囊性纤维化的新生儿筛查婴儿在一岁时，肺部疾病的结构、功能和炎症标志物变化极小。
J Cyst Fibros. 2020 Nov;19(6):896-901. doi: 10.1016/j.jcf.2020.01.006. Epub 2020 Feb 7.
6
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.依伐卡托与泰比卡托和艾克卡托三联复方药物治疗携带单个 F508del 突变的囊性纤维化
N Engl J Med. 2019 Nov 7;381(19):1809-1819. doi: 10.1056/NEJMoa1908639. Epub 2019 Oct 31.
7
An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB).KLIMB 研究：在 2-5 岁有 CFTR 门控突变的 CF 患儿中开展 ivacaftor 的开放标签扩展研究，以启动治疗。
J Cyst Fibros. 2019 Nov;18(6):838-843. doi: 10.1016/j.jcf.2019.03.009. Epub 2019 Apr 30.
8
Techniques for minimizing sedation in pediatric MRI.减轻儿科 MRI 镇静的技术。
J Magn Reson Imaging. 2019 Oct;50(4):1047-1054. doi: 10.1002/jmri.26703. Epub 2019 Mar 14.
9
Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor.来自美国和英国囊性纤维化注册中心的数据支持 CFTR 调节剂 ivacaftor 对疾病的修饰作用。
Thorax. 2018 Aug;73(8):731-740. doi: 10.1136/thoraxjnl-2017-210394. Epub 2018 May 10.
10
Pulmonary function deficits in newborn screened infants with cystic fibrosis managed with standard UK care are mild and transient.在接受英国标准护理的新生儿筛查出患有囊性纤维化的婴儿中，肺功能缺陷是轻微且短暂的。
Eur Respir J. 2017 Nov 9;50(5). doi: 10.1183/13993003.00326-2017. Print 2017 Nov.
Zotero 插件